Insider · CIK 0001283303
Elizabeth E Reed
Files at TVTX (Travere Therapeutics, Inc.). First filing May 5, 2025, latest Sep 17, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TVTX: Travere Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Travere Therapeutics, Inc. | $2.3M 37,500 shares | -26% | +175% from low-7% from high | |
| 0Weak | Travere Therapeutics, Inc. | $250k 10,000 shares | -10% | +89% from low-7% from high | |
| 5Weak | Travere Therapeutics, Inc. | $104k 4,920 shares | -5% | +75% from low-10% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +37,500 | $15.46 | $580k | 142,889 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -21,926 | $62.03 | $1.4M | 120,963 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -13,874 | $62.63 | $869k | 107,089 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,400 | $63.69 | $89k | 105,689 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -300 | $65.31 | $20k | 105,389 | 25 d ago |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -37,500 | $0.00 | $0 | 0 | 25 d ago |
| Sep 22, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +10,000 | $19.08 | $191k | 99,878 | Sep 24, 2025 |
| Sep 22, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,000 | $25.00 | $250k | 89,878 | Sep 24, 2025 |
| Sep 22, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Employee stock option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 40,000 | Sep 24, 2025 |
| May 2, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +4,920 | - | - | 94,402 | May 5, 2025 |
| May 5, 2025 | TVTX Travere Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -4,920 | $21.05 | $104k | 89,482 | May 5, 2025 |
| May 2, 2025 | TVTX Travere Therapeutics, Inc. | MOption exercise Performance-based restricted stock unitsderivative10b5-1 | -4,920 | $0.00 | $0 | 4,920 | May 5, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.